Table 2. Unadjusted venous thromboembolism incidence rates by clinical characteristics.
| VTE/N | VTE rate (%) | 95% CI | p-value | |
|---|---|---|---|---|
|
| ||||
| Total | 93/943 | 9.9 | 8.0,12.0 | -- |
|
| ||||
| Age§ | 0.99* | 0.97,1.01 | 0.41 | |
|
| ||||
| Gender | ||||
| Male | 66/731 | 9.0 | 7.0,11.3 | 0.09 |
| Female | 27/207 | 13.0 | 8.8,18.4 | |
|
| ||||
| Race | ||||
| Caucasian | 83/863 | 9.6 | 7.7,11.8 | 0.38 |
| Other | 9/70 | 12.9 | 6.1,23.0 | |
|
| ||||
| Primary tumor location | ||||
| Bladder | 81/777 | 10.4 | 8.4,12.8 | 0.26 |
| Other | 11/149 | 7.4 | 3.7,12.8 | |
|
| ||||
| Histology | ||||
| Urothelial | 76/863 | 8.8 | 7.0,10.9 | <0.001 |
| Non-urothelial | 17/80 | 21.3 | 12.9,31.8 | |
|
| ||||
| Primary treated with surgery | ||||
| Surgery | 48/539 | 8.9 | 6.6,11.6 | 0.26 |
| No surgery | 45/404 | 11.1 | 8.2,14.6 | |
|
| ||||
| Primary treated with radiation | ||||
| Radiation | 5/48 | 10.4 | 3.5,22.7 | 0.81 |
| No radiation | 88/895 | 9.8 | 8.0,12.0 | |
|
| ||||
| CVD or CVD risk factors | ||||
| Yes | 64/496 | 12.9 | 10.1,16.2 | 0.001 |
| No | 29/447 | 6.5 | 4.4,9.2 | |
|
| ||||
| Renal dysfunction | ||||
| Yes | 13/77 | 16.9 | 9.3,27.1 | 0.03 |
| No | 80/866 | 9.2 | 7.4,11.4 | |
|
| ||||
| COPD | ||||
| Yes | 6/82 | 7.3 | 2.7,15.3 | 0.42 |
| No | 87/861 | 10.1 | 8.2,12.3 | |
|
| ||||
| Congestive heart failure | ||||
| Yes | 2/26 | 7.7 | 1.0, 25.1 | 1.00 |
| No | 91/917 | 9.9 | 8.1,12.0 | |
|
| ||||
| Khorana risk group | ||||
| High-risk (≥3) | 21/162 | 13.0 | 8.2,19.1 | 0.15 |
| Intermediate-risk (1-2) | 72/781 | 9.2 | 7.3,11.5 | |
|
| ||||
| WBC count (WBC/ul)§ | 1.00* | 0.96,1.05 | 0.92 | |
|
| ||||
| Hemoglobin (g/dl)§ | 1.01* | 0.91,1.13 | 0.82 | |
|
| ||||
| Platelet count (plt/ul)§ | 1.00* | 0.998, 1.001 | 0.67 | |
|
| ||||
| Body mass index (kg/m2)§ | 1.04* | 1.00, 1.08 | 0.08 | |
§
Calculated as continuous variables
*
Results indicate odds ratios for the given variables